Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
3.270
+0.080 (2.51%)
Dec 5, 2025, 4:00 PM EST - Market closed
Erasca Employees
Erasca had 103 employees as of December 31, 2024. The number of employees decreased by 23 or -18.25% compared to the previous year.
Employees
103
Change (1Y)
-23
Growth (1Y)
-18.25%
Revenue / Employee
n/a
Profits / Employee
-$1,239,670
Market Cap
927.74M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103 | -23 | -18.25% |
| Dec 31, 2023 | 126 | -3 | -2.33% |
| Dec 31, 2022 | 129 | 6 | 4.88% |
| Dec 31, 2021 | 123 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ERAS News
- 11 days ago - Erasca to Present at the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 23 days ago - Erasca Reports Third Quarter 2025 Business Updates and Financial Results - GlobeNewsWire
- 4 weeks ago - Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015 - GlobeNewsWire
- 4 weeks ago - Erasca to Present at Upcoming Conferences in November - GlobeNewsWire
- 3 months ago - Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Erasca Reports Second Quarter 2025 Business Updates and Financial Results - GlobeNewsWire
- 6 months ago - Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001 - GlobeNewsWire
- 6 months ago - Erasca to Present at Upcoming Investor Conferences in June - GlobeNewsWire